Showing results (41-50 of 308) with videos related to
Sort By:
Pageof 31
Journal of Medical Virology|June 29, 2007
Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis CS Mrani, I Chemin, K Menouar, et al.Journal of Hepatology|June 8, 2001
Preliminary results of interferon-alpha therapy on woodchuck hepatitis virus-induced hepatocarcinogenesis: possible benefit in female transgenic miceP Merle, M Chevallier, R Levy, et al.Antimicrobial Agents and Chemotherapy|March 21, 2001
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virusF Le Guerhier, C Pichoud, C Jamard, et al.Antimicrobial Agents and Chemotherapy|April 4, 1998
Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replicationS Aguesse-Germon, S H Liu, M Chevallier, et al.Gastroenterologie Clinique Et Biologique|July 30, 2008
[Combination therapy in chronic hepatitis B]C Fournier, F ZoulimJournal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 8, 2006
Clinical impact of occult HBV infectionsI Chemin, C TrépoBailliere'S Best Practice & Research. Clinical Gastroenterology|July 13, 2000
HCV: epidemiology, modes of transmission and prevention of spreadP Pradat, C TrépoGastroenterologie Clinique Et Biologique|April 12, 2008
Long-term results of liver transplantation for Wilson's diseaseV Pabón, J Dumortier, R Gincul, et al.Intervirology|October 12, 1999
New antiviral agents for the therapy of chronic hepatitis B virus infectionF Zoulim, C TrepoPageof 31